MPC vs RXRX · P/E 16, rev $138.86B vs rev $58.8M
Marathon Petroleum Corp (MPC) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the MPC and RXRX stock pages for the full models.
Not investment advice.